WebOther Haymarket Medical Network Websites. Cancer Therapy Advisor; Clinical Advisor; Clinical Pain Advisor; Dermatology Advisor; Endocrinology Advisor; Gastroenterology … Web1 hour ago · Haymarket Medical Network Cancer Therapy Advisor Clinical Advisor Clinical Pain Advisor Dermatology Advisor Endocrinology Advisor Gastroenterology Advisor Hematology Advisor Infectious Disease...
Cardiology News, Research Articles Heart Disease, Disorder Studies
Web3 hours ago · Primary bleeding events were reported by more C-PCI recipients (2.9%) than non-C-PCI recipients (2.2%; P <.001). Among the C-PCI cohort, risk for bleeding outcomes was lower among the P2Y 12 inhibitor recipients compared with standard DAPT recipients (hazard ratio [HR], 0.66; 95% CI, 0.44-0.98; I 2, 40.0%).This pattern was stronger among … WebScroll below the course listing for information on other useful myCME pages and resources. Recommended Video Activities NEW! Collaborating with Patients to Achieve Clinical Trial Equity in Non-Hodgkin Lymphoma Video CME 1.00 Credit View Details Top Rated! Community Practice Connections™: Ophthalmology Times® EyeCon 2024 Video royalty manor dearborn heights
FDA Clears Implantable Shock Absorber to Treat Knee OA
Web1 hour ago · Of note, the study that used an individual psychologic treatment intervention as comparator had an effect size in the opposite direction (g, 0.69; 95% CI, 0.17-1.22), … Web6 hours ago · Rheumatoid arthritis (RA) may not be a significant risk factor for adverse events (AEs) during initiation of immune checkpoint inhibitors (ICIs) for cancer treatment, according to research results published in BMC Rheumatology.. Researchers aimed to evaluate whether preexisting RA was associated with a higher mortality and risk for … http://www.haymarketmedicaleducation.com/ royalty management software